F. Ross

1.2k total citations
28 papers, 773 citations indexed

About

F. Ross is a scholar working on Surgery, Rheumatology and Hematology. According to data from OpenAlex, F. Ross has authored 28 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 4 papers in Rheumatology and 4 papers in Hematology. Recurrent topics in F. Ross's work include Wound Healing and Treatments (3 papers), Diagnosis and Treatment of Venous Diseases (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). F. Ross is often cited by papers focused on Wound Healing and Treatments (3 papers), Diagnosis and Treatment of Venous Diseases (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). F. Ross collaborates with scholars based in United States, United Kingdom and Spain. F. Ross's co-authors include Christine Moffatt, Debra Doherty, Peter Franks, Ruth Martin, Gretl Lam, Ernest S. Chiu, R Fontaine, Richard J. Gilbertson, John A. Crolla and James C. Nicholson and has published in prestigious journals such as The American Journal of Medicine, British Journal of Cancer and Journal of Vascular Surgery.

In The Last Decade

F. Ross

26 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Ross United States 13 228 222 221 168 126 28 773
Elaine Herer Canada 11 203 0.9× 278 1.3× 129 0.6× 136 0.8× 157 1.2× 19 856
Sultan Bahabri Saudi Arabia 18 93 0.4× 413 1.9× 137 0.6× 278 1.7× 14 0.1× 39 1.4k
Francesca Ferlito Italy 14 201 0.9× 581 2.6× 244 1.1× 491 2.9× 35 0.3× 35 1.4k
J R Nash United Kingdom 18 151 0.7× 130 0.6× 240 1.1× 134 0.8× 42 0.3× 41 874
Maria Cristina Tirindelli Italy 19 131 0.6× 135 0.6× 141 0.6× 325 1.9× 29 0.2× 58 1.0k
Kristin Henry United Kingdom 18 266 1.2× 102 0.5× 218 1.0× 83 0.5× 17 0.1× 29 1.4k
Giulio Maggio Italy 9 29 0.1× 120 0.5× 220 1.0× 20 0.1× 142 1.1× 19 948
Einar Andreas Sivertsen Norway 21 58 0.3× 231 1.0× 573 2.6× 67 0.4× 82 0.7× 36 1.1k
Jean‐Philippe Hauzeur Belgium 23 382 1.7× 125 0.6× 1.1k 4.9× 64 0.4× 22 0.2× 49 1.8k
Hugo Burgos United Kingdom 13 47 0.2× 69 0.3× 243 1.1× 98 0.6× 102 0.8× 21 664

Countries citing papers authored by F. Ross

Since Specialization
Citations

This map shows the geographic impact of F. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ross more than expected).

Fields of papers citing papers by F. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ross. The network helps show where F. Ross may publish in the future.

Co-authorship network of co-authors of F. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ross. A scholar is included among the top collaborators of F. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ross. F. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Angela, Shannon Frank, K. H. Baines, et al.. (2023). 231P Trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK: Real-world data. ESMO Open. 8(1). 101419–101419. 1 indexed citations
2.
Alfonso, Allyson R., et al.. (2020). Management of stage 0 medication-related osteonecrosis of the jaw with hyperbaric oxygen therapy: a case report and review of the literature. Undersea and Hyperbaric Medicine. 47(2). 241–251. 2 indexed citations
3.
Ross, F., Ernest S. Chiu, Bedros Taslakian, et al.. (2019). A Descriptive Revenue Analysis of a Wound-Center IR Collaboration to Treat Lower Extremity Venous Ulcers. Journal of Vascular and Interventional Radiology. 30(12). 1988–1993.e1.
4.
Lam, Gretl, R Fontaine, F. Ross, & Ernest S. Chiu. (2017). Hyperbaric Oxygen Therapy: Exploring the Clinical Evidence. Advances in Skin & Wound Care. 30(4). 181–190. 78 indexed citations
5.
Lam, Gretl, F. Ross, & Ernest S. Chiu. (2017). Nonhealing Ulcers in Patients with Tophaceous Gout: A Systematic Review. Advances in Skin & Wound Care. 30(5). 230–237. 12 indexed citations
6.
Ginocchio, Luke, et al.. (2017). Refractory Ulcerated Necrobiosis Lipoidica: Closure of a Difficult Wound with Topical Tacrolimus. Advances in Skin & Wound Care. 30(10). 469–472. 6 indexed citations
7.
McMeeking, Alexander, et al.. (2014). Wounds in Patients with HIV. Advances in Skin & Wound Care. 27(9). 396–403. 4 indexed citations
8.
Avet‐Loiseau, Hervé, Brian G.M. Durie, Michèle Cavo, et al.. (2012). Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project. Leukemia. 27(3). 711–717. 126 indexed citations
9.
Blumberg, Sheila, J. Carlos Maggi, Jonathan Melamed, et al.. (2012). A Histopathologic Basis for Surgical Debridement to Promote Healing of Venous Ulcers. Journal of the American College of Surgeons. 215(6). 751–757. 11 indexed citations
10.
Berger, Alexandra, Sheila Blumberg, Daniel I. O’Neill, et al.. (2011). A multidisciplinary team approach to hydroxyurea‐associated chronic wound with squamous cell carcinoma. International Wound Journal. 9(3). 324–329. 15 indexed citations
11.
Odero, María D., Francis Grand, Sameena Iqbal, et al.. (2004). Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia. 19(2). 245–252. 56 indexed citations
12.
Moffatt, Christine, et al.. (2004). Prevalence of leg ulceration in a London population. QJM. 97(7). 431–437. 164 indexed citations
13.
Nicholson, James C., F. Ross, John A. Crolla, et al.. (2002). Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. British Journal of Cancer. 86(6). 929–939. 111 indexed citations
14.
Myint, Han, Joseph Chacko, Sarah Mould, F. Ross, & David Oscier. (1995). Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation. British Journal of Haematology. 90(2). 462–464. 13 indexed citations
15.
Macchioni, P., Luigi Boiardi, Carlo Salvarani, et al.. (1993). LYMPHOCYTE SUBPOPULATIONS ANALYSIS IN PERIPHERAL BLOOD IN POLYMYALGIA RHEUMATICA/GLANT CELL ARTERITIS. Lara D. Veeken. 32(8). 666–670. 17 indexed citations
16.
Shimshi, Mona, et al.. (1992). Virilizing adrenocortical tumor superimposed on congenital adrenocortical hyperplasia. The American Journal of Medicine. 93(3). 338–342. 6 indexed citations
17.
Mann, William J., et al.. (1990). Management of gastric outlet obstruction caused by ovarian cancer. Gynecologic Oncology. 40(3). 277–279. 3 indexed citations
18.
Jay, Gregory D., F. Ross, Richard Mason, & F. Girón. (1989). Clinical and chemical characterization of an adventitial popliteal cyst. Journal of Vascular Surgery. 9(3). 448–451. 5 indexed citations
19.
Ross, F.. (1985). Community issues. 3. A challenging district.. PubMed. 160(8). 35–7. 1 indexed citations
20.
Ross, F.. (1980). Primary health care in Thamesmead - 1.. PubMed. 76(30). suppl 76: 81–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026